Internal Medicine, Medical Oncology · Saint Louis, MO
NPI
1174787162
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
915 N Grand Blvd
Saint Louis, MO, 63106
Phone (314) 651-4100
Groups this clinician bills Medicare through
Medicare paid, 2024
$545K
21,002 services
Medicare patients, 2024
167
Average age 73
Drug cost, 2024
$900K
330 prescriptions
Company payments, 2025
$115
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jesse W Keller was code J9299 (injection, nivolumab, 1 mg), 7,280 times for 12 patients. In total Jesse W Keller billed 21,002 services in 92 codes, and Medicare paid $545K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9299 Injection, nivolumab, 1 mg | Office | 7,280 | 12 | $24.38 | $177K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 220 | 15 | $0.09 | $20.32 |
| 99214 Office E&M - Established | Office | 148 | 61 | $93.05 | $14K |
| 99442 Telephone Services | Office | 105 | 49 | $65.67 | $6,896 |
| 96413 Chemotherapy Administration | Office | 68 | 48 | $96.50 | $6,562 |
| 96375 Injection Administration | Office | 33 | 16 | $11.53 | $380 |
| 96367 Intravenous Infusion, Hydration | Office | 25 | 17 | $21.27 | $532 |
| 96372 Injection Administration | Office | 23 | 18 | $10.87 | $250 |
| 96417 Chemotherapy Administration | Office | 19 | 11 | $47.58 | $904 |
| 99204 Office E&M - New | Office | 16 | 16 | $114.38 | $1,830 |
| 96402 Chemotherapy Administration | Office | 15 | 15 | $24.77 | $371 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 13 | 12 | $2.08 | $27.07 |
By year: 2022 $250K for 12,337 services; 2023 $19K for 211 services; 2024 $545K for 21,002 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jesse W Keller prescribed most often to Medicare patients was Prednisone, with 52 prescriptions and refills. In total Jesse W Keller wrote 330 Medicare prescriptions that cost $900K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 52 | 64 | 18 | $169 |
| Mekinist Trametinib Dimethyl Sulfoxide | 24 | 24 | Under 11 | $380K |
| Tafinlar Dabrafenib Mesylate | 24 | 24 | Under 11 | $350K |
| Oxycodone Hcl Generic | 20 | 20 | Under 11 | $229 |
| Levothyroxine Sodium Generic | 18 | 42 | Under 11 | $304 |
| Cotellic Cobimetinib Fumarate | 13 | 13 | Under 11 | $74K |
| Sertraline Hcl Generic | 11 | 11 | Under 11 | $69.64 |
| Zelboraf Vemurafenib | 11 | 11 | Under 11 | $51K |
Brand drugs: 104 claims; generic drugs: 226 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jesse W Keller $115 ($115 in general payments such as food, travel and fees) from 2 companies. The largest payer was Dendreon Pharmaceuticals LLC with $115.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 1 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.